Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis

Donglin Ding, Alexandra M. Blee, Jianong Zhang, Yunqian Pan, Nicole A. Becker, L. James Maher, Rafael Jimenez, Liguo Wang, Haojie Huang

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis'. Together they form a unique fingerprint.

Physics & Astronomy

Medicine & Life Sciences

Chemical Compounds